BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4527863)

  • 21. Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase.
    Jameel PZ; Lohiya S; Dongre A; Damke S; Lakhkar BB
    BMC Pediatr; 2020 May; 20(1):228. PubMed ID: 32423425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent diabetes and ketoacidosis due to L-asparaginase therapy.
    Varsano I; Zaizov R; Nitzan M
    Helv Paediatr Acta; 1973 Oct; 28(4):365-9. PubMed ID: 4519479
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoregulation of L-asparaginase-induced diabetes mellitus.
    Boston B; Rosen M; Capizzi RL
    Cancer Treat Rep; 1977 Nov; 61(8):1607-9. PubMed ID: 270391
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperglycemia associated with the therapeutic use of L-asparaginase: possible role of insulin receptors.
    Carpentieri U; Balch MT
    J Pediatr; 1978 Nov; 93(5):775-8. PubMed ID: 712479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocyst.
    Greenstein R; Nogeire C; Ohnuma T; Greenstein A
    Cancer; 1979 Feb; 43(2):718-22. PubMed ID: 283880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase.
    King OY; Wilbur JR; Mumford DM; Sutow WW
    Cancer; 1974 Mar; 33(3):611-4. PubMed ID: 4592901
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of acute lymphocytic leukemia complicated with multiple pancreatic pseudocysts probably caused by L-asparaginase].
    Izumi Y; Konishi H; Mochizuki T; Ishikura H; Usui T; Sawada H; Miyake T; Uchino H
    Rinsho Ketsueki; 1984 Jan; 25(1):57-62. PubMed ID: 6589415
    [No Abstract]   [Full Text] [Related]  

  • 30. Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS).
    Hashii Y; Yoshida M; Hara J; Nishimura S; Yumura-Yagi K; Horibe K; Nakahata T
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):374-378. PubMed ID: 29697579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection of chemotherapy-related pancreatic enlargement in children using abdominal sonography: a preliminary report.
    Samuels BI; Culbert SJ; Okamura J; Sullivan MP
    Cancer; 1976 Oct; 38(4):1515-23. PubMed ID: 991074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia.
    Gillette PC; Hill LL; Starling KA; Fernbach DJ
    J Pediatr; 1972 Jul; 81(1):109-11. PubMed ID: 5034858
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
    Thu Huynh V; Bergeron S
    Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic pancreatitis. A fatal complication in the induction therapy for acute lymphocytic leukemia.
    Jain R; Ramanan SV
    Arch Intern Med; 1978 Nov; 138(11):1726. PubMed ID: 281192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute diabetic metabolic disorders during therapy of lymphoblastic leukemias].
    Kegel J; Gadner H; Riehm H; Weber B
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):694-5. PubMed ID: 4528132
    [No Abstract]   [Full Text] [Related]  

  • 38. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase.
    Dacou-Voutetakis C; Palis J; Haidas S; Zannos-Mariolea L; Georgiopoulou P; Matsaniotis N
    Am J Pediatr Hematol Oncol; 1983; 5(2):139-46. PubMed ID: 6351658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia.
    Raja RA; Schmiegelow K; Sørensen DN; Frandsen TL
    Pediatr Blood Cancer; 2017 Jan; 64(1):32-38. PubMed ID: 27555294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between modified CT severity index and clinical features of L-asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia.
    Oh HJ; Im SA; Lee JW; Chung NG; Cho B
    Pediatr Hematol Oncol; 2014 Oct; 31(7):647-55. PubMed ID: 24933500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.